CIBC Private Wealth Group
NVO

CIBC Private Wealth Group’s Novo Nordisk NVO Stock Holding History

CIBC Private Wealth Group’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q4 		$12.2M Sell
239,760
-112,711
-32% -$5.76M 0.02% 328
2025
Q3 		$19.6M Buy
352,471
+7,404
+2% +$433K 0.03% 286
2025
Q2 		$23.8M Buy
345,067
+13,404
+4% +$912K 0.04% 263
2025
Q1 		$20.4M Buy
331,663
+287,784
+656% +$23.8M 0.04% 248
2024
Q4 		$3.76M Sell
43,879
-13,733
-24% -$1.49M 0.01% 470
2024
Q3 		$6.86M Sell
57,612
-1,995
-3% -$266K 0.01% 382
2024
Q2 		$8.53M Sell
59,607
-2,971
-5% -$394K 0.02% 343
2024
Q1 		$7.98M Sell
62,578
-588
-0.9% -$70K 0.02% 351
2023
Q4 		$6.53M Sell
63,166
-851
-1% -$84.2K 0.01% 357
2023
Q3 		$5.82M Buy
64,017
+38,479
+151% +$3.39M 0.01% 367
2023
Q2 		$2.07M Sell
25,538
-2,476
-9% -$202K ﹤0.01% 497
2023
Q1 		$701K Buy
28,014
+706
+3% +$50.1K ﹤0.01% 660
2022
Q4 		$1.35M Buy
27,308
+298
+1% +$17.5K ﹤0.01% 477
2022
Q3 		$1.34M Buy
27,010
+20,626
+323% +$1.1M ﹤0.01% 544
2022
Q2 		$356K Buy
6,384
+68
+1% +$3.77K ﹤0.01% 769
2022
Q1 		$351K Buy
6,316
+372
+6% +$19.1K ﹤0.01% 821
2021
Q4 		$333K Buy
5,944
+110
+2% +$5.96K ﹤0.01% 849
2021
Q3 		$280K Hold
5,834
– – ﹤0.01% 829
2021
Q2 		$244K Sell
5,834
-27,096
-82% -$1.05M ﹤0.01% 951
2021
Q1 		$1.11M Buy
32,930
+27,096
+464% +$965K ﹤0.01% 649
2020
Q4 		$204K Sell
5,834
-344
-6% -$11.9K ﹤0.01% 948
2020
Q3 		$214K Buy
+6,178
New +$206K ﹤0.01% 831
2020
Q2 		– Sell
-25,084
Closed -$755K – 740
2020
Q1 		$755K Sell
25,084
-118
-0.5% -$3.51K ﹤0.01% 556
2019
Q4 		$729K Buy
+25,202
New +$698K ﹤0.01% 644
2018
Q4 		– Sell
-8,496
Closed -$200K – 927
2018
Q3 		$200K Buy
8,496
+7,986
+1,566% +$195K ﹤0.01% 926
2018
Q2 		$12K Sell
510
-26
-5% -$618 ﹤0.01% 1520
2018
Q1 		$13K Sell
536
-77,706
-99% -$2.04M ﹤0.01% 1475
2017
Q4 		$2.1M Sell
78,242
-27,390
-26% -$697K 0.01% 494
2017
Q3 		$2.54M Sell
105,632
-30,000
-22% -$678K 0.01% 440
2017
Q2 		$2.91M Buy
+135,632
New +$2.74M 0.02% 336
2016
Q4 		– Sell
-90,680
Closed -$1.89M – 591
2016
Q3 		$1.89M Sell
90,680
-9,836
-10% -$244K 0.01% 370
2016
Q2 		$2.7M Sell
100,516
-10,632
-10% -$292K 0.02% 327
2016
Q1 		$3.01M Sell
111,148
-2,912
-3% -$78K 0.02% 308
2015
Q4 		$3.31M Sell
114,060
-1,112
-1% -$30.8K 0.03% 303
2015
Q3 		$3.12M Buy
115,172
+3,474
+3% +$98.4K 0.03% 311
2015
Q2 		$3.06M Buy
111,698
+1,360
+1% +$38.2K 0.02% 330
2015
Q1 		$2.95M Buy
110,338
+14,726
+15% +$339K 0.02% 335
2014
Q4 		$2.02M Buy
95,612
+4,166
+5% +$93.1K 0.02% 372
2014
Q3 		$2.18M Buy
91,446
+2,432
+3% +$56K 0.02% 360
2014
Q2 		$2.06M Sell
89,014
-886
-1% -$19.6K 0.02% 359
2014
Q1 		$2.05M Buy
+89,900
New +$1.92M 0.02% 361

Other funds holding NVO

Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $79.8B AUM 16.05% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
F
Folketrygdfondet Oslo Norway, Norway $4.64B AUM 35.47% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

CIBC Private Wealth Group's NVO Position: Q4 2025 in Review

CIBC Private Wealth Group reduced its Novo Nordisk (NVO) stake by 32% in Q4 2025, selling an estimated $5.76M and leaving 239,760 shares worth $12.2M. The position accounts for 0.02% of the portfolio, ranked #328.

CIBC Private Wealth Group first reported a position in NVO in Q1 2014 and has held it in 41 quarters since. The position peaked at $23.8M in Q2 2025. 1,418 funds tracked by Wall St. Rank hold NVO as of Q4 2025.

  • CIBC Private Wealth Group held 239,760 shares of Novo Nordisk worth $12.2M as of Q4 2025.
  • CIBC Private Wealth Group sold 112,711 Novo Nordisk shares in Q4 2025, an estimated $5.76M.
  • Novo Nordisk made up 0.02% of CIBC Private Wealth Group's portfolio in Q4 2025, its #328 holding.
  • CIBC Private Wealth Group first reported a position in Novo Nordisk in Q1 2014 and has held it in 41 quarters since.
  • CIBC Private Wealth Group's Novo Nordisk position peaked at $23.8M in Q2 2025.
  • 1,418 funds tracked by Wall St. Rank held Novo Nordisk as of Q4 2025.

Based on CIBC Private Wealth Group's 13F filing for Q4 2025, filed 12 Feb 2026.